Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.
Clinical trial NCT04625725 · COMPLETED
Trial details
- NCT number
- NCT04625725
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-21
- Primary completion
- 2022-08-16
- Enrollment
- 5197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.